CN103330759A - 一种治疗鼻炎的中药组合物及其制备方法 - Google Patents
一种治疗鼻炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103330759A CN103330759A CN2013102998234A CN201310299823A CN103330759A CN 103330759 A CN103330759 A CN 103330759A CN 2013102998234 A CN2013102998234 A CN 2013102998234A CN 201310299823 A CN201310299823 A CN 201310299823A CN 103330759 A CN103330759 A CN 103330759A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- chinese medicine
- flos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 138
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 206010039083 rhinitis Diseases 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 239000009636 Huang Qi Substances 0.000 claims abstract description 10
- 241000218378 Magnolia Species 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 58
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 51
- 229940079593 drug Drugs 0.000 claims description 41
- 238000002360 preparation method Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 24
- 238000000605 extraction Methods 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- 238000004821 distillation Methods 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000002552 dosage form Substances 0.000 claims description 12
- 241001116389 Aloe Species 0.000 claims description 11
- 235000014435 Mentha Nutrition 0.000 claims description 11
- 241001072983 Mentha Species 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 235000011399 aloe vera Nutrition 0.000 claims description 11
- 239000009670 cang er zi wan Substances 0.000 claims description 11
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 9
- 239000011347 resin Substances 0.000 claims description 9
- 229920005989 resin Polymers 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 235000008504 concentrate Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 241000545442 Radix Species 0.000 claims description 4
- 241001180876 Saposhnikovia Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000829 suppository Substances 0.000 claims description 4
- 229920000742 Cotton Polymers 0.000 claims description 3
- 230000000274 adsorptive effect Effects 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 241000931705 Cicada Species 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241000501098 Sargentodoxa Species 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 230000002262 irrigation Effects 0.000 claims description 2
- 238000003973 irrigation Methods 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 230000008719 thickening Effects 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 3
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 2
- 240000004370 Pastinaca sativa Species 0.000 abstract 2
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 abstract 2
- 235000006751 Platycodon Nutrition 0.000 abstract 2
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 2
- 229930189914 platycodon Natural products 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241001660870 Cyrtomium Species 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000007853 Sarothamnus scoparius Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 210000004894 snout Anatomy 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 241000700199 Cavia porcellus Species 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 206010028748 Nasal obstruction Diseases 0.000 description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 8
- 210000002850 nasal mucosa Anatomy 0.000 description 8
- 206010018691 Granuloma Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000000416 exudates and transudate Anatomy 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000003928 nasal cavity Anatomy 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 210000000959 ear middle Anatomy 0.000 description 6
- 210000003097 mucus Anatomy 0.000 description 6
- 210000001331 nose Anatomy 0.000 description 6
- 206010020565 Hyperaemia Diseases 0.000 description 5
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 229940023488 pill Drugs 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 240000006409 Acacia auriculiformis Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 229940100691 oral capsule Drugs 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 201000009151 chronic rhinitis Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000003118 histopathologic effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 241000053227 Themus Species 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 208000038016 acute inflammation Diseases 0.000 description 2
- 230000006022 acute inflammation Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 210000000883 ear external Anatomy 0.000 description 2
- 210000003094 ear ossicle Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 229960000785 fluocinonide Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010050515 Hyposmia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 238000000556 factor analysis Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 235000019559 hyposmia Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013010 irrigating solution Substances 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000003695 paranasal sinus Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | n | 肉芽肿重量(g) |
模型组 | 10 | 0.12532±0.015673 |
醋酸氟轻松组 | 10 | 0.09873±0.009634* |
本发明高剂量组 | 10 | 0.06548±0.008763* |
本发明低剂量组 | 10 | 0.08643±0.000621 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310299823.4A CN103330759B (zh) | 2013-07-17 | 2013-07-17 | 一种治疗鼻炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310299823.4A CN103330759B (zh) | 2013-07-17 | 2013-07-17 | 一种治疗鼻炎的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103330759A true CN103330759A (zh) | 2013-10-02 |
CN103330759B CN103330759B (zh) | 2015-02-04 |
Family
ID=49239009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310299823.4A Expired - Fee Related CN103330759B (zh) | 2013-07-17 | 2013-07-17 | 一种治疗鼻炎的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103330759B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599200A (zh) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | 一种治疗慢性鼻窦炎的中药 |
CN104000953A (zh) * | 2014-04-25 | 2014-08-27 | 万强胜 | 一种治疗鼻炎的中药组合物 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN104997949A (zh) * | 2015-08-02 | 2015-10-28 | 哈尔滨凝昇科技有限公司 | 一种治疗鼻炎的中药组合物及其制备方法 |
CN105168669A (zh) * | 2015-10-28 | 2015-12-23 | 郭旺水 | 一种治疗中耳炎的中药组合物及其制备方法和用途 |
CN115531514A (zh) * | 2022-11-15 | 2022-12-30 | 王岭 | 一种治疗鼻炎的中药组合物及其中药制剂 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813702A (zh) * | 2012-09-10 | 2012-12-12 | 李韶华 | 鼻炎药水 |
-
2013
- 2013-07-17 CN CN201310299823.4A patent/CN103330759B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102813702A (zh) * | 2012-09-10 | 2012-12-12 | 李韶华 | 鼻炎药水 |
Non-Patent Citations (1)
Title |
---|
卢长云: "敛肺通窍汤治疗过敏性鼻炎120例", 《四川中医》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103599200A (zh) * | 2013-11-19 | 2014-02-26 | 太和县中医院 | 一种治疗慢性鼻窦炎的中药 |
CN103599200B (zh) * | 2013-11-19 | 2015-04-29 | 太和县中医院 | 一种治疗慢性鼻窦炎的中药 |
CN104000953A (zh) * | 2014-04-25 | 2014-08-27 | 万强胜 | 一种治疗鼻炎的中药组合物 |
CN104997949A (zh) * | 2015-08-02 | 2015-10-28 | 哈尔滨凝昇科技有限公司 | 一种治疗鼻炎的中药组合物及其制备方法 |
CN104971264A (zh) * | 2015-08-10 | 2015-10-14 | 王艳娣 | 一种治疗小儿慢性鼻窦炎的中药组合物 |
CN105168669A (zh) * | 2015-10-28 | 2015-12-23 | 郭旺水 | 一种治疗中耳炎的中药组合物及其制备方法和用途 |
CN115531514A (zh) * | 2022-11-15 | 2022-12-30 | 王岭 | 一种治疗鼻炎的中药组合物及其中药制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103330759B (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103330759B (zh) | 一种治疗鼻炎的中药组合物及其制备方法 | |
CN102139030B (zh) | 一种治疗牙龈炎的口腔中药制剂及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN102000194B (zh) | 一种治疗中耳炎的中药组合物及其制备方法 | |
CN102614413B (zh) | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 | |
CN102614306A (zh) | 治疗慢性鼻窦炎的中药制剂 | |
CN1327875C (zh) | 治疗慢性盆腔炎的中药制剂及其制备方法 | |
CN103720841B (zh) | 一种治疗慢性化脓性中耳炎的中药制剂及其制备方法 | |
CN103735845A (zh) | 一种治疗小儿分泌性中耳炎的中药外用制剂及其制备方法 | |
CN103656377A (zh) | 一种内外兼治慢性前列腺炎的中药药物 | |
CN103721138B (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN101053612B (zh) | 妇科外用的中药洁阴剂及其洁阴凝膏 | |
CN104706953A (zh) | 一种治疗慢性子宫颈炎的中药制剂 | |
CN104116953A (zh) | 一种治疗尿路结石的中药 | |
CN103341059A (zh) | 一种治疗非淋菌性尿道炎的中药组合物 | |
CN102657709A (zh) | 一种治疗鼻炎的中药 | |
CN103341044B (zh) | 止痒复方制剂及其制备方法 | |
CN102743623B (zh) | 一种治疗尿频尿急型滴虫性阴道炎的中药洗剂制备方法 | |
CN104306789A (zh) | 一种治疗肾炎的中药 | |
CN102743519B (zh) | 一种治疗肝火炽盛型滴虫性阴道炎的中药洗剂制备方法 | |
CN107375577A (zh) | 治疗过敏性鼻炎的中药组合物及其熏洗剂制备方法 | |
CN113663049B (zh) | 一种黎药产后药浴泡腾颗粒及其制备方法 | |
CN102205057B (zh) | 一种治疗结膜充血型小儿流行性感冒的中药的制备方法 | |
CN103110737B (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN102727675B (zh) | 一种治疗鼻窦炎的中药胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: DU WENZE CAI HUIPING ZHENG YI LU LIYAO Effective date: 20150106 Owner name: YUE TING Free format text: FORMER OWNER: WANG LEI Effective date: 20150106 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Yue Ting Inventor after: Du Wenze Inventor after: Cai Huiping Inventor after: Zheng Yi Inventor after: Lu Liyao Inventor before: Wang Lei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250012 JINAN, SHANDONG PROVINCE TO: 200237 XUHUI, SHANGHAI Free format text: CORRECT: INVENTOR; FROM: WANG LEI TO: YUE TING DU WENZE CAI HUIPING ZHENG YI LU LIYAO |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150106 Address after: 200237 Meilong Road, Shanghai, No. 130, No. Applicant after: Yue Ting Applicant after: Du Wenze Applicant after: Cai Huiping Applicant after: Zheng Yi Applicant after: Lu Liyao Address before: 250012 Shandong, Lixia District, Ji'nan Province Cultural Road West, No. 107 Applicant before: Wang Lei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150204 Termination date: 20150717 |
|
EXPY | Termination of patent right or utility model |